Crossmark

Chronic Myelomonocytic Leukemia Microenvironment in Disease Progression and Therapy: Focus on Stepwise Reconfiguring of Myeloid-Immune Cell Interactions Driving Immune Tolerance

Crossref DOI link: https://doi.org/10.1007/s11899-025-00757-y

Published Online: 2025-09-26

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alsugair, Ali Khalid A

Mangaonkar, Abhishek
Funding

Funding for this research was provided by:

Mayo Clinic Center for Clinical and Translational Science (CCaTS) Benefactor Career Development Award

American Cancer Society (CSDG-23-1020347-01-IBCD)
License Information

Text and Data Mining valid from 2025-09-26

Version of Record valid from 2025-09-26
More Information

Article History

Received: 14 June 2025

Accepted: 1 September 2025

First Online: 26 September 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below